Advisory Limits Stem Cell Use for Autism to Approved Clinical Trials
The advisory mandates that stem cell interventions for Autism Spectrum Disorder be confined to clinical trials approved under the National Guidelines for Stem Cell Research, 2017. Any unapproved use, prescription, or promotion is classified as professional misconduct.